BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37081108)

  • 1. Astragaloside IV suppresses the migration and EMT progression of cervical cancer cells by inhibiting macrophage M2 polarization through TGFβ/Smad2/3 signaling.
    Shen L; Li Y; Hu G; Song X; Wang X; Li X; Xu X
    Funct Integr Genomics; 2023 Apr; 23(2):133. PubMed ID: 37081108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling.
    Xu F; Cui WQ; Wei Y; Cui J; Qiu J; Hu LL; Gong WY; Dong JC; Liu BJ
    J Exp Clin Cancer Res; 2018 Aug; 37(1):207. PubMed ID: 30157903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of NFATc1/c-myc/PKM2/IL-10 axis in activating cervical cancer tumor-associated M2 macrophage polarization to promote cervical cancer progression.
    Tan J; Yang L; Zhao H; Ai Y; Ren L; Zhang F; Dong W; Shi R; Sun D; Feng Y
    Exp Cell Res; 2022 Apr; 413(2):113052. PubMed ID: 35122827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF-κB/STAT3 signaling pathway.
    Min L; Wang H; Qi H
    Am J Transl Res; 2022; 14(3):1551-1566. PubMed ID: 35422920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway.
    Liu CY; Xu JY; Shi XY; Huang W; Ruan TY; Xie P; Ding JL
    Lab Invest; 2013 Jul; 93(7):844-54. PubMed ID: 23752129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis.
    Wang X; Gao S; Song L; Liu M; Sun Z; Liu J
    Mol Immunol; 2021 Feb; 130():113-121. PubMed ID: 33308900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
    Zhu L; Fu X; Chen X; Han X; Dong P
    Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Associated Macrophages Derived TGF-β‒Induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells through Smad2,3-4/Snail Signaling Pathway.
    Cai J; Xia L; Li J; Ni S; Song H; Wu X
    Cancer Res Treat; 2019 Jan; 51(1):252-266. PubMed ID: 29690747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

  • 10. Ionizing Radiation Promotes Epithelial-to-Mesenchymal Transition in Lung Epithelial Cells by TGF-β-producing M2 Macrophages.
    Park HR; Jo SK; Jung U
    In Vivo; 2019; 33(6):1773-1784. PubMed ID: 31662502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.
    Chen X; Yang M; Yin J; Li P; Zeng S; Zheng G; He Z; Liu H; Wang Q; Zhang F; Chen D
    Cell Commun Signal; 2022 Jun; 20(1):92. PubMed ID: 35715860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragaloside IV antagonizes the malignant progression of breast cancer induced by macrophage M2 polarization through the TGF-β-regulated Akt/Foxo1 pathway.
    Yu Y; Hao J; Wang L; Zheng X; Xie C; Liu H; Wu J; Qiao S; Shi J
    Pathol Res Pract; 2023 Sep; 249():154766. PubMed ID: 37633006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroartemisinin Prevents Progression and Metastasis of Head and Neck Squamous Cell Carcinoma by Inhibiting Polarization of Macrophages in Tumor Microenvironment.
    Chen R; Lu X; Li Z; Sun Y; He Z; Li X
    Onco Targets Ther; 2020; 13():3375-3387. PubMed ID: 32425545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MnTE-2-PyP Attenuates TGF-
    Yang Y; Zhang P; Yan R; Wang Q; Fang E; Wu H; Li S; Tan H; Zhou X; Ma X; Tang Y; Huang Y; Deng R; Liu Y; Tong S; Wang Z; Oberley-Deegan RE; Tong Q
    Oxid Med Cell Longev; 2019; 2019():8639791. PubMed ID: 30931081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atractylenolide II inhibits tumor-associated macrophages (TAMs)-induced lung cancer cell metastasis.
    Zhang Y; Liu Y; Wang J; Jiang Z; Zhang L; Cui Y; Zhao D; Wang Y
    Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):227-237. PubMed ID: 35166628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mediator of phosphorylated Smad2/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells.
    Yang W; Gong X; Wang X; Huang C
    Invest New Drugs; 2019 Oct; 37(5):865-875. PubMed ID: 30488243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin Suppresses M2 Macrophage-derived Paclitaxel Chemoresistance through Inhibition of PI3K-AKT/STAT3 Signaling.
    Deswal B; Bagchi U; Kapoor S
    Anticancer Agents Med Chem; 2024; 24(2):146-156. PubMed ID: 37957871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 Positive Feedback Loop Between Cancer Cells and Tumor-Associated Macrophages Promotes Osteosarcoma Migration and Invasion.
    Hou C; Lu M; Lei Z; Dai S; Chen W; Du S; Jin Q; Zhou Z; Li H
    Lab Invest; 2023 May; 103(5):100054. PubMed ID: 36801636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole inhibits invasion and migration of pancreatic cancer cells by suppressing TGF-β/SMAD2/3 signaling.
    Chen K; Cheng L; Qian W; Jiang Z; Sun L; Zhao Y; Zhou Y; Zhao L; Wang P; Duan W; Ma Q; Yang W
    Oncol Rep; 2018 Apr; 39(4):1573-1582. PubMed ID: 29484419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.